Cardiac anticoagulation therapy plays a pivotal role in the nuanced landscape of cardiovascular care. Tailored to individuals at risk of blood clot formation, this specialized therapy is a key element in preventing potential complications such as strokes or heart attacks. Commonly prescribed for conditions like atrial fibrillation, deep vein thrombosis, or those with mechanical heart valves, cardiac anticoagulation therapy involves the use of medications like warfarin or direct oral anticoagulants. These medications exert their effect by disrupting the blood clotting process, promoting a smoother flow of blood through the heart and vessels. The meticulous administration of cardiac anticoagulation therapy demands vigilant monitoring and personalized dosing to strike an optimal balance between preventing clots and minimizing the risk of bleeding complications. As research in the medical field progresses, ongoing refinements in cardiac anticoagulation therapies hold the promise of enhanced efficacy, reduced side effects, and improved overall outcomes for individuals managing cardiovascular conditions.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation